Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 30 Oct 2024
- Closes
- 7 Jan 2028, 23:59 UTC
- Reference
- PAR-25-185
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)”. Submissions close on 7 January 2028, 454 days from today. Quote reference PAR-25-185 in any correspondence with the buyer. FreeTender has recorded 430 notices from this buyer since 2023, 378 of them currently open. There are 368 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Details
Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including human congenital anomalies (HCAs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs). Large quantities of genomic data collected from pediatric congenital anomalies cohorts are available to the research community through several databases such as the Database of Genotypes and Phenotypes (dbGaP), the Gabriella Miller Kids First Data Resource Portal, the European Genome-Phenome Archive and Clinical Genome Resource (ClinGen). The purpose of this initiative is to promote the screening, functional validation and characterization of congenital anomaly-associated genetic variants identified through public facing databases and individual efforts using in-silico tools, appropriate animal models, in vitro systems or multi-pronged approaches. This initiative addresses a challenging gap between identifying sequence variations of potential interest and recognizing which of those variations have functional effects on the phenotype of interest. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
CFDA number(s): 93.121
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 430 notices from National Institutes of Health, going back to May 2023 — 378 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 368 open Healthcare & Pharma tenders in United States. This one closes in 454 days.
More from this buyer
- Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)· closes 14 Dec
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)· closes 14 Dec
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)· closes 9 Feb
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)· closes 13 Oct
- NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)· closes 1 Mar
Similar Healthcare & Pharma tenders
- Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)· closes 14 Dec
- Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)· closes 23 Nov
- Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)· closes 23 Nov
- IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)· closes 14 Dec
- Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)· closes 14 Dec
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Повторный закуп изделий медицинского назначенияРеспубликанское государственное учреждение "Центральный военный госпиталь с поликлиникой Комитета национальной безопасности Республики Казахстан" · Kazakhstan
- О проведении государственной закупки товара для НАО «Казахский национальный медицинский университет имени С. Д. Асфендиярова» способом открытого конкурса — Аппарат искусственного кровообращенияНекоммерческое акционерное общество "Казахский национальный медицинский университет имени С. Д. Асфендиярова" · Kazakhstan
- Public notice regarding procurement of reagents for hematology analyzer at Dr Hedgewar Arogya SansthanHealth & Family Welfare Department, Govt. of NCT of Delhi · India
- услуг по медицинскому освидетельствованиюРеспубликанское государственное учреждение "Служба правительственной связи Комитета национальной безопасности Республики Казахстан" · Kazakhstan
- Изделия медицинского назначенияРеспубликанское государственное предприятие "Больница Медицинского центра Управления Делами Президента Республики Казахстан" на праве хозяйственного ведения · Kazakhstan
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →